Clinical trial evaluating apomorphine oromucosal solution in Parkinson's disease patients
Abstract Apomorphine, used to treat OFF episodes in patients with Parkinson's disease (PD), is typically administered via subcutaneous injections. Administration of an oromucosal solution could offer a non‐invasive and user‐friendly alternative. This two‐part clinical study evaluated the safety...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Format: | Book |
Published: |
Wiley,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!